<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>New insights into the pathogenesis of lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> have been gained through novel techniques such as genetic, molecular and immunologic methods </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, based on those findings, a new classification system for lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, known as the REAL classification, has been proposed </plain></SENT>
<SENT sid="2" pm="."><plain>To clarify the relation between the histological classification and prognosis of B-cell lymphoid <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, we re-classified 708 cases </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases, the B-<z:mp ids='MP_0005384'>cell phenotype</z:mp> and/or genotype was confirmed by immunohistochemical staining and/or receptor gene analysis </plain></SENT>
<SENT sid="4" pm="."><plain>The most common B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> types were diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (58.8%), follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (12.1%), marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of mucosa-associated lymphoid tissue (MALT) (9.0%) and mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (5.9%) </plain></SENT>
<SENT sid="5" pm="."><plain>Minor types were lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (3.4%), Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (2.4%), nodal marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (2.1%), lymphoplasmacytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (2.0%) and <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo> (1.4%) </plain></SENT>
<SENT sid="6" pm="."><plain>Rare types were prolymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and splenic marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>Using overall survival rates, the various B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> types could be divided into three broad groups for prognostic purposes: (1) the low risk group consisted of follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of MALT, nodal marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:hpo ids='HP_0011857'>plasmacytoma</z:hpo> and lymphoplasmacytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; (2) the intermediate risk group consisted of diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; and (3) the high risk group consisted of lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>In MALT, the low grade type had a better prognosis than the high grade type </plain></SENT>
<SENT sid="9" pm="."><plain>In diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, the common type had a better prognosis than the variant type, which mainly consisted of the <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="10" pm="."><plain>The histological classification will have a benefit for the clinical approach </plain></SENT>
</text></document>